(Q53051521)

English

Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer. (English)

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

quality of life

1 reference

based on heuristic

inferred from title

Zakaria Einbeigi

4

object named as

Zakaria Einbeigi

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Thomas Hatschek

2

object named as

Thomas Hatschek

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

author name string

Helene Svensson

1

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Hemming Johansson

3

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Yvonne Brandberg

5

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

publication date

6 February 2011

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Medical Oncology

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

29

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

2

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

432-438

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

https://scigraph.springernature.com/pub.10.1007/s12032-011-9844-9

0 references

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Prognostic factors for patients with hepatic metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Prognostic and predictive factors in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Prognostic factors in 1,038 women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine).

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

A bootstrap resampling procedure for model building: Application to the cox regression model

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Factors affecting health-related quality of life in women with recurrent breast cancer in Korea.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Symptom clusters in patients with advanced cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9844-9

21 January 2018

A note on quantifying follow-up in studies of failure time

1 reference

https://pubmed.ncbi.nlm.nih.gov/21298494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21298494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of a structured training program in breast cancer patients with tumor-related chronic fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21298494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer-related fatigue: guidelines for evaluation and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/21298494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-011-9844-9

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/21298494

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53051521&oldid=1739271247"